Media Coverage

Media articles featuring INFORMS members in the news.

Most Recent Media Coverage

Topic
Variable Pricing Boosts NFL Ticket Sales: Study

Variable Pricing Boosts NFL Ticket Sales: Study

Mirage News, January 25, 2023

How can a sports team win off the field with variable ticket pricing strategies? A new study in the INFORMS journal Management Science sheds light on the adoption of variable pricing increases in primary market ticket sales by looking at National Football League (NFL) ticket markets.

MIT Experts on What You Need to Know Now about Data Analytics

MIT Experts on What You Need to Know Now about Data Analytics

Inside Big Data, January 24, 2023

Data drives efficiencies, increases profitability, and bolsters innovation. Yet analytics skills remain outside the wheelhouse of many business leaders, who don’t always have a clear view of what data sources and analyses are necessary to formulate the insights they are seeking.

Ladimer S. and Anna B. Nagurney: Appreciate column on Ukraine

Ladimer S. and Anna B. Nagurney: Appreciate column on Ukraine

Daily Hampshire Gazette, January 23, 2023

We would like to commend Dr. DavideGottsegen for his insightful column, “As war rolls on, support for Ukraine must continue,” in the Jan. 20 Gazette. He eloquently and correctly condenses the issues, outlines the over 1,000 year history of Ukraine and its people, and documents why Ukraine and Ukrainians are totally blameless in this unjustified, unprovoked war by Russia on this sovereign nation in Eastern Europe. As children of the Ukrainian diaspora, we learned about many of the topics noted in Gottsegen’s excellent column in our Ukrainian Saturday school classes on Ukraine, its language, culture, history, and religion. We are pleased and touched that he took the time and made the effort to share his wisdom with our community.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
asmith@informs.org
443-757-3578

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Artificial Intelligence

Healthcare

Falling demand sees J&J scale back COVID-19 vaccine

Falling demand sees J&J scale back COVID-19 vaccine

Pharmaphorum, January 16, 2023

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. In the past few months, the New Brunswick, New Jersey-based pharmaceutical company has terminated manufacturing agreements with companies that helped to produce the vaccine during the pandemic, including Catalent and Sanofi.

 

Supply Chain

Falling demand sees J&J scale back COVID-19 vaccine

Falling demand sees J&J scale back COVID-19 vaccine

Pharmaphorum, January 16, 2023

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. In the past few months, the New Brunswick, New Jersey-based pharmaceutical company has terminated manufacturing agreements with companies that helped to produce the vaccine during the pandemic, including Catalent and Sanofi.

 

Climate